Curriculum Vitaes
Profile Information
- Affiliation
- Fujita Health University
- Degree
- 博士 (医学)(九州大学)
- J-GLOBAL ID
- 201801011682533471
- researchmap Member ID
- B000307191
香川県高松市生まれ。1996年に富山医科薬科大学医学部を卒業後九州大学神経内科に入局、佐賀医科大学病院、九州大学病院、麻生飯塚病院で臨床神経内科学の臨床研究を行った。その後、国立循環器病研究センター、福岡市民病院、小倉記念病院、九州大学病院、済生会福岡病院、藤田医科大学で主に脳梗塞診療プロセスの改善と教育、そのICT支援に関する研究を中心に行っている。ICTを活用することで、脳卒中診療に関わるスタッフの想いや技術を全国の脳卒中患者さんに効果的に届けることで、脳卒中のダメージを最小限にすることがメインテーマである。
Research History
17-
Jul, 2020 - Present
-
Oct, 2018 - Jun, 2020
-
Apr, 2018 - Sep, 2018
-
Oct, 2016 - Mar, 2018
-
Apr, 2016 - Sep, 2016
Education
1-
Apr, 1990 - Mar, 1996
Awards
1Papers
96-
Neurointervention, Jun 27, 2025PURPOSE: The Woven EndoBridge (WEB) was introduced in Japan in January 2021 and approved for all subtypes of wide-neck bifurcation aneurysms (WNBA). This retrospective study evaluated the safety and efficacy of the WEB device for all subtypes of WNBA. MATERIALS AND METHODS: All patients treated with the WEB at our facility between January 2021 and May 2024 was reviewed. We selected the WEB device according to an oversizing policy, based on cumulative clinical evidence from global experience. RESULTS: We analyzed 120 aneurysms in 117 patients (56 males and 61 females with a mean age of 65.5±12.7 years). There were 45 anterior communicating artery aneurysms, 27 middle cerebral artery aneurysms, 17 internal carotid artery-posterior communicating artery aneurysms, 15 basilar artery top aneurysms, and 16 aneurysms in other locations. Aneurysm characteristics included a maximum diameter of 6.5 [5.3, 7.7] mm, height of 4.9 [3.9, 6.0] mm, width of 4.8 [4.0, 6.2] mm, and dome/neck ratio of 1.2 [1.1, 1.4]. All data are expressed in median [interquartile range]. Angiographic follow-up at 12 months in 96 cases showed complete obliteration in 68.8% and adequate obliteration in 90.6% of cases. Intraoperative ischemic events occurred in 5 cases (4.2%). Hemorrhagic events occurred in 2 cases (1.7%), with symptoms resolving by discharge, except for 1 case of mild paralysis. During follow-up, 1 patient developed a major stroke, resulting in morbidity (0.8%). Retreatment was required in 3 cases (2.5%). On multivariate analysis for complete occlusion at 12 months following WEB treatment, age was statistically associated with the outcome (odds ratio, 0.957 per year; 95% confidence interval, 0.919-0.996; P=0.033). CONCLUSION: WEB is safe and effective for all subtypes of WNBA, with a low retreatment rate using an oversizing policy. This is the first report in a Japanese population.
-
Journal of NeuroInterventional Surgery, jnis-2025, Jun 20, 2025Purpose Digital subtraction angiography (DSA) is the gold standard for follow-up evaluation of intracranial aneurysms treated with the Woven EndoBridge (WEB) device. This study aimed to assess the efficacy of high-resolution CT angiography (HR-CTA) as a less invasive alternative by comparing its diagnostic performance with that of DSA. Methods This single-center retrospective study analyzed the angiographic and clinical data of patients treated with the WEB device for cerebral aneurysms between January 2021 and December 2024. Patients who underwent HR-CTA within 2 weeks before or after follow-up DSA were included. Occlusion status was assessed using the Bicêtre Occlusion Scale Score (BOSS) and binary classification. The concordance rate between HR-CTA and DSA was evaluated. Results A total of 54 eligible examinations were identified. Using the BOSS, 46 examinations were concordant, resulting in an agreement rate of 85.2%. The Cohen’s κ coefficient was 0.81 (95% CI 0.69 to 0.93), indicating a very high level of agreement. All discordant cases resulted from HR-CTA overestimating occlusion status; however, HR-CTA accurately identified aneurysm remnants. Univariate analyses identified BOSS 0’ as the only significant factor contributing to discrepancies. In the binary evaluation, all 54 examinations were fully concordant (κ=1.00, 95% CI 1.00 to 1.00). Conclusions HR-CTA demonstrated a high concordance rate with DSA for evaluating occlusion status after WEB placement. Its reliable assessment of aneurysm remnants suggests HR-CTA could serve as a practical and less invasive alternative to DSA in follow-up evaluations.
-
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 135 111192-111192, May, 2025BACKGROUND: This study aimed to determine the efficacy of flow diverters (FDs) for small/medium (≤10 mm) aneurysms and analyzed the factors that prevent aneurysm occlusion. METHODS: This retrospective single-center study evaluated the angiographic and clinical data of consecutive patients between June 2020 and February 2023. RESULTS: Overall, 121 small/medium aneurysms were observed in 106 patients treated with FDs. The median dome diameter was 6.1 (5.1-7.2) mm. Symptomatic thromboembolic complications were observed in four (3.7 %) patients, and none showed a major ischemic stroke. Intracranial hemorrhage was detected using postprocedural computed tomography in one (0.9 %) patient with asymptomatic subarachnoid hemorrhage. The rate of permanent neurological deficits was 1.8 %, and the mortality rate was 0 %. No delayed ischemic or hemorrhagic complications were observed during follow-up. Angiographic follow-up revealed complete and adequate occlusion (O'Kelly-Marotta grades C and D) rates of 77.5 % and 90.8 %, respectively. On multivariate analysis, incomplete occlusion was only associated with the presence of a branch vessel from the aneurysm dome (P < 0.01). In aneurysms with incorporated branch vessels, univariate analysis revealed that coil usage was a predictor of complete occlusion (P = 0.03). Moreover, even without using coils, effective occlusion was achieved when the branch vessel diameter was small (P = 0.03). CONCLUSIONS: FDs are an effective and safe treatment option for small/medium aneurysms. The presence of incorporated branch vessels can predict incomplete occlusion. Even in aneurysms with incorporated branch vessels, FD can obtain therapeutic effects by adding coil embolization or treating with only FD if the branch vessel diameter is small.
-
J Med Ultrason (2001). 2025 Apr 17. doi: 10.1007/s10396-025-01522-7. Epub ahead of print. PMID: 40244313., Apr, 2025 Peer-reviewed
-
Asian journal of neurosurgery, 20(1) 143-148, Mar, 2025We report a case in which a novel distal access catheter proved successful in the placement of a flow diverter for a challenging distal cerebral artery lesion. We discuss the advantages and pitfalls of this technique and considerations for its use. A 74-year-old female presented with intermittent headaches, and was diagnosed with a dissecting aneurysm at the proximal right posterior cerebral artery with a sharp bleb, measuring 9.8 mm in diameter. Given the complex vascular anatomy, stent-assisted coil embolization was initially considered but deemed high risk for dual catheter for jailing technique with 6-Fr size guiding catheter due to the tortuosity and stenosis of the parent vessel. Therefore, we opted for flow diverter treatment, which presented its challenges during delivery. By employing a low-profile distal access catheter, Phenom Plus (outer diameter: 4.2-Fr. inner diameter: 1.13 mm; Medtronic, Minneapolis, Minnesota, United States), with a minimal ledge between it and the delivery catheter, Phenom 27 (outer diameter: 2.8-Fr, 0.91 mm; Medtronic), we successfully crossed the neck of the aneurysm with Phenom Plus and placed the flow diverter. While acknowledging potential risks, this case demonstrates the value of the neck-crossing technique using a low-profile distal access catheter as an alternative option for treating challenging peripheral artery aneurysms with flow diverters. This technique offers promise in specific situations where conventional methods pose challenges.
Misc.
288-
脳卒中, 32(3) 296-300, May, 201075歳女性。患者は65歳時より高血圧症、慢性心不全、心房細動でワルファリン、ACE阻害薬の内服中であった。今回、床に倒れているのを発見され救急搬送された。意識レベルはJCS 100、roving eye movement、右上下肢不全片麻痺と失語がみられ、NIHSSは35点であった。MRIでは左中大脳動脈領域に淡い高信号域が散在しており、MRAでは左中大脳動脈M2以降の描出不良が認められた。以上より、本症例は心原性塞栓症と判断し、rt-PA静注療法を開始したところ、右上下肢不全麻痺は改善し、NIHSS 21点となったが、舌と口腔底に著明な浮腫が出現、血管性浮腫の診断にてメチルプレドニゾロンの点滴が行われた。その結果、舌の腫大は消失、自発語がみられ、NIHSSは16点にまで改善したものの、経過とともに意識障害の増悪、右共同偏視が出現した。以後、MRIで右中大脳動脈領域に脳梗塞再発を確認し、へパリンナトリウムとワルファリン投与を行い、舌の腫大は完全消失となった。
-
JNET: Journal of Neuroendovascular Therapy, 3(4) 177-177, Nov, 2009
-
JNET: Journal of Neuroendovascular Therapy, 3(4) 297-297, Nov, 2009
-
JNET: Journal of Neuroendovascular Therapy, 2(4) 169-169, Nov, 2008
-
JNET: Journal of Neuroendovascular Therapy, 2(4) 261-261, Nov, 2008
-
日本脳神経外科学会総会CD-ROM抄録集, 67回 1I-O28, Oct, 2008
-
STROKE, 39(2) 553-553, Feb, 2008
-
STROKE, 39(2) 725-725, Feb, 2008
-
Journal of Neuroendovascular Therapy, 2(1) 56-61, 2008
-
JNET: Journal of Neuroendovascular Therapy, 1(2) 109-109, Nov, 2007
-
JNET: Journal of Neuroendovascular Therapy, 1(2) 136-136, Nov, 2007
-
JNET: Journal of Neuroendovascular Therapy, 1(2) 166-166, Nov, 2007
-
JNET: Journal of Neuroendovascular Therapy, 1(2) 208-208, Nov, 2007
-
JNET: Journal of Neuroendovascular Therapy, 1(2) 226-226, Nov, 2007
-
JNET: Journal of Neuroendovascular Therapy, 1(2) 279-279, Nov, 2007
-
日本脳神経外科学会総会CD-ROM抄録集, 66回 2K-P19, Oct, 2007
-
The Mt. Fuji Workshop on CVD, 25 88-92, Jul, 2007頸部頸動脈急性閉塞に対して血管内手技による血行再建を行った10例の成績を報告した。症例の内訳は頸部内頸動脈閉塞9例、総頸動脈閉塞1例で、閉塞の原因は心原性塞栓症4例、アテローム血栓症4例、特発性動脈解離1例、頸動脈ステント留置術後遠隔期のステント内閉塞1例であった。治療方法は、病態に応じて血栓吸引、PTA、ステント留置を行った。成績は、心原性塞栓症が原因の4例ではいずれも再開通が得られず予後不良であったが、他の6例は再開通が得られた。再開通例のうち3例では良好な転帰が得られ、2例では治療前に比べて神経症状が改善したが、1例はその後症状が悪化し死亡した。代表例として、アテローム血栓性の左内頸動脈閉塞に対して血栓吸引+ステント留置を行った1例と、アテローム血栓性の右内頸動脈閉塞に対して血栓吸引+ステント留置+PTAを行った1例を提示した。
Presentations
77Professional Memberships
5Research Projects
8-
科学研究費助成事業, 日本学術振興会, Apr, 2025 - Mar, 2028
-
科学研究費助成事業, 日本学術振興会, Apr, 2023 - Mar, 2026
-
日本医療研究開発機構(AMED) 2023年12月 - 2026年3月, Dec, 2023 - Mar, 2026
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2021 - Mar, 2024
-
産学が連携した研究開発成果の展開 研究成果展開事業 研究成果最適展開支援プログラム(A-STEP) トライアウト トライアウトタイプ(標準), 科学技術振興機構, 2021 - 2021